BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24656168)

  • 1. Short and long term in vivo effects of Cyclosporine A and Sirolimus on genes and proteins involved in lipid metabolism in Wistar rats.
    Lopes PC; Fuhrmann A; Sereno J; Espinoza DO; Pereira MJ; Eriksson JW; Reis F; Carvalho E
    Metabolism; 2014 May; 63(5):702-15. PubMed ID: 24656168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model.
    Fuhrmann A; Lopes P; Sereno J; Pedro J; Espinoza DO; Pereira MJ; Reis F; Eriksson JW; Carvalho E
    Biochem Pharmacol; 2014 Mar; 88(2):216-28. PubMed ID: 24462915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue.
    Pereira MJ; Palming J; Rizell M; Aureliano M; Carvalho E; Svensson MK; Eriksson JW
    Mol Cell Endocrinol; 2013 Jan; 365(2):260-9. PubMed ID: 23160140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model.
    Lopes P; Fuhrmann A; Sereno J; Pereira MJ; Nunes P; Pedro J; Melão A; Reis F; Carvalho E
    Transplant Proc; 2013 Apr; 45(3):1142-8. PubMed ID: 23622647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment.
    Lopes PC; Fuhrmann A; Carvalho F; Sereno J; Santos MR; Pereira MJ; Eriksson JW; Reis F; Carvalho E
    Biochem Pharmacol; 2014 Sep; 91(1):61-73. PubMed ID: 24960264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and renal tissue markers of nephropathy in rats under immunosuppressive therapy: cyclosporine versus sirolimus.
    Sereno J; Parada B; Rodrigues-Santos P; Lopes PC; Carvalho E; Vala H; Teixeira-Lemos E; Alves R; Figueiredo A; Mota A; Teixeira F; Reis F
    Transplant Proc; 2013 Apr; 45(3):1149-56. PubMed ID: 23622648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS; Kim CT; Kim Y
    Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension induced by immunosuppressive drugs: a comparative analysis between sirolimus and cyclosporine.
    Reis F; Parada B; Teixeira de Lemos E; Garrido P; Dias A; Piloto N; Baptista S; Sereno J; Eufrásio P; Costa E; Rocha-Pereira P; Santos-Silva A; Figueiredo A; Mota A; Teixeira F
    Transplant Proc; 2009 Apr; 41(3):868-73. PubMed ID: 19376375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene.
    Han DH; Piao SG; Song JH; Ghee JY; Hwang HS; Choi BS; Kim J; Yang CW
    Transplantation; 2010 Jul; 90(2):135-41. PubMed ID: 20562737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporine and sirolimus on fatty acid desaturase activities in cultured HEPG2 cells.
    Lausada N; de Gómez Dumm IN; Raimondi JC; de Alaniz MJ
    Transplant Proc; 2009 Jun; 41(5):1865-70. PubMed ID: 19545746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat-reducing effects of dehydroepiandrosterone involve upregulation of ATGL and HSL expression, and stimulation of lipolysis in adipose tissue.
    Karbowska J; Kochan Z
    Steroids; 2012 Nov; 77(13):1359-65. PubMed ID: 22951290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
    Bai S; Brunner LJ; Stepkowski SM; Napoli KL; Kahan BD
    Transplantation; 2001 Jun; 71(11):1585-92. PubMed ID: 11435969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lpin1 in human visceral and subcutaneous adipose tissue: similar levels but different associations with lipogenic and lipolytic genes.
    Miranda M; Escoté X; Alcaide MJ; Solano E; Ceperuelo-Mallafré V; Hernández P; Wabitsch M; Vendrell J
    Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E308-17. PubMed ID: 20530740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway.
    Martin-Martin N; Slattery C; McMorrow T; Ryan MP
    Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1281-92. PubMed ID: 21880834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different immunosuppressive therapies on the lipid pattern in kidney-transplanted rats.
    Lausada N; de Gómez Dumm Nelva T; Georgina L; Gisela C; Clemente R
    Transpl Int; 2005 May; 18(5):524-31. PubMed ID: 15819800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporine.
    Morales JM; Hartmann A; Walker R; Arns W; Senatorski G; Grinyó JM; Shoker A; Wilczek H; Jamieson NV; Lelong M; Brault Y; Burke JT; Scarola JA;
    Transplant Proc; 2009; 41(6):2339-44. PubMed ID: 19715914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
    Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
    Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
    Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ
    Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM; Campistol JM; Kreis H; Mourad G; Eris J; Schena FP; Grinyo JM; Nanni G; Andres A; Castaing N; Brault Y; Burke JT
    Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.